Dapagliflozin-Induced Myocardial Flow Reserve Improvement is not Associated with HDL Ability to Stimulate Endothelial Nitric Oxide Production.
Umberto CapeceChiara PavanelloFrancesca CintiLucia LeccisottiTeresa MezzaGea CiccarelliSimona MoffaGianfranco Di GiuseppeLaura SoldovieriMichela BrunettiAlessandro GiordanoAndrea GiaccariLaura CalabresiAlice OssoliPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2023)
EudraCT No. 2016-003614-27; ClinicalTrials.gov Identifier: NCT03313752.